Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, USA.
AAPS J. 2021 Mar 14;23(2):43. doi: 10.1208/s12248-021-00561-5.
Modern diagnostic technologies rely on both in vitro and in vivo modalities to provide a complete understanding of the clinical state of a patient. Nanoparticle-antibody conjugates have emerged as promising systems to confer increased sensitivity and accuracy for in vitro diagnostics (e.g., immunoassays). Meanwhile, in vivo applications have benefited from the targeting ability of nanoparticle-antibody conjugates, as well as payload flexibility and tailored biodistribution. This review provides an encompassing overview of nanoparticle-antibody conjugates, from chemistry to applications in medical immunoassays and tumor imaging, highlighting the underlying principles and unique features of relevant preclinical applications employing commonly used imaging modalities (e.g., optical/photoacoustics, positron-emission tomography, magnetic resonance imaging, X-ray computed tomography).
现代诊断技术依赖于体外和体内两种模式,以全面了解患者的临床状况。纳米粒子-抗体缀合物已成为提高体外诊断(例如免疫测定)的灵敏度和准确性的有前途的系统。同时,体内应用得益于纳米粒子-抗体缀合物的靶向能力,以及有效载荷的灵活性和定制的生物分布。本综述从化学角度全面概述了纳米粒子-抗体缀合物,及其在医学免疫测定和肿瘤成像中的应用,重点介绍了使用常用成像模式(例如光学/光声,正电子发射断层扫描,磁共振成像,X 射线计算机断层扫描)的相关临床前应用的基本原理和独特特征。